Cancer stem cells: cell culture, markers, and targets for new therapies.
about
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cellsGlioblastoma Stem Cells as a New Therapeutic Target for GlioblastomaA new prospect in cancer therapy: targeting cancer stem cells to eradicate canceruPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cellsThe future role of personalized medicine in the treatment of glioblastoma multiformeCancer stem cells: a systems biology view of their role in prognosis and therapyEpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic PatientsEnrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.Lipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cellsClinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres.Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrenceTherapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells.High-throughput, miniaturized clonogenic analysis of a limiting dilution assay on a micropillar/microwell chip with brain tumor cells.Biological characteristics of a new human glioma cell line transformed into A2B5(+) stem cells.Human cytomegalovirus gene expression in long-term infected glioma stem cells.Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with γ-secretase inhibitorA Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells.Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cellsDose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitorEffective elimination of cancer stem cells by a novel drug combination strategy.Establishment of human iPSC-based models for the study and targeting of glioma initiating cellsStandardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.Understanding and targeting cancer stem cells: therapeutic implications and challenges.Clinical trial design for testing the stem cell model for the prevention and treatment of cancer.Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.Loss-of-function screens of druggable targetome against cancer stem-like cells.Strategies for highly sensitive biomarker detection by Rolling Circle Amplification of signals from nucleic acid composed sensors.Characteristic features of stem cells in glioblastomas: from cellular biology to genetics.Clinical implication of targeting of cancer stem cells.Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview.Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors.Cancer stem cell detection and isolation.Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
P2860
Q24293124-A5CC8823-011E-434E-AF07-502C3ADF4D7BQ26776219-B8CE92A2-EABD-46D1-B89F-23D9587E9C2EQ27022134-438BB51B-E468-4D27-A973-A03B08440A4AQ28237374-B68CE74E-95AC-4C68-84D5-6FA6A97CBC05Q28391635-3DEAFC08-355F-43B6-B502-E82175ABC6AAQ33569712-62C184F8-0E38-4CF7-AE40-6522EE9CA921Q33722366-550E16FE-8245-47F3-8603-52F88B3115C5Q33747768-E7625329-CB16-4EEC-98B9-172A4CF46CD3Q33799308-4DAE1ED1-941F-4ADA-B3A7-5C930E80B57AQ34037067-ECA9C014-1CF7-4759-8B46-0DB0F884D170Q34047392-4863AD82-4CF1-4CC5-AE69-889E655BEDA4Q34101839-59A4887A-30FB-48EA-A67D-371F8C785746Q34154786-1939B249-85CE-4B84-879F-4E004133B2B2Q34481639-F5C30175-9BD7-4ABE-B3B0-F0DE0AF144DEQ34770728-0E0A38AD-326A-4EAB-ACC9-0E3BAAFD808EQ35048739-65EF1A3F-DC14-45FD-A6C3-451656E82C76Q35257037-B0CFC993-92B7-4C58-A257-E50518641DFDQ35354646-17D01111-037F-4F3D-BEA2-44FA62673E3FQ35535809-804A2980-BEE7-4E19-B42E-E018FAC4B5DAQ35605171-7B21E807-28D3-4DBA-B42F-52392D5A1C7AQ35677134-04F9F032-2E5D-4300-9731-647A0998AC3AQ36163766-57F5D2AD-BF7A-4005-AB99-022A0CDA4645Q36229244-BBA08766-0DBF-49AC-8FF1-CF7CEBE70DD8Q36382605-5279E373-3A4A-4492-8479-33AC16336F34Q36428239-55120EC5-4057-413A-A63B-5569AC1FD58CQ36452882-61EC14C0-FC45-4C66-A899-31B9F64307C8Q36512795-6A427F77-7364-44AD-9E0F-67007771443EQ36611096-E9FA8FA0-439B-4E3E-85FA-D3CC8064DA74Q36627739-C323334B-2B3E-4517-8A84-43E6F125D86CQ36907405-F8235542-A4C3-4EFB-A9D0-94195BDC66D5Q37132809-F2C084E9-8F8F-467E-8F2E-63C0BAA114A1Q37213241-29E209A6-34CC-44CE-8790-06A5184DAADFQ37589846-1F9E074C-4C9A-4BC7-A07B-0FC5A114FE62Q37934584-A91792F6-4BC6-493F-A72C-AA7797E89169Q37981219-A8312F81-EA00-4FD2-927F-7A4EF6924155Q38026464-9FEB460A-2947-4E04-9BD7-EBFE4B6B6A19Q38057886-EBD9CEEB-ED83-47B1-B5FB-2A90FC7F4DBCQ38139850-C42855A3-C985-4911-A842-AF6F11D7DD1DQ38234251-F823364B-E819-4C88-93F3-AEC7292D1ADEQ38322466-39C03AF0-53F0-4331-A6CD-88C12DDA7EBE
P2860
Cancer stem cells: cell culture, markers, and targets for new therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer stem cells: cell culture, markers, and targets for new therapies.
@en
Cancer stem cells: cell culture, markers, and targets for new therapies.
@nl
type
label
Cancer stem cells: cell culture, markers, and targets for new therapies.
@en
Cancer stem cells: cell culture, markers, and targets for new therapies.
@nl
prefLabel
Cancer stem cells: cell culture, markers, and targets for new therapies.
@en
Cancer stem cells: cell culture, markers, and targets for new therapies.
@nl
P2860
P356
P1476
Cancer stem cells: cell culture, markers, and targets for new therapies.
@en
P2093
Alonzo H Ross
Candace A Gilbert
P2860
P304
P356
10.1002/JCB.22350
P577
2009-12-01T00:00:00Z